TABLE OF CONTENTS

2024-9-4

Mesenchymal Stromal Cell therapy for Hypoxic Ischemic Encephalopathy: Future directions for combination therapy with hypothermia and/or melatonin

2024-8-1

Parental impact during and after Neonatal Intensive Care admission

2024-8-1

Effects of pain, sedation and analgesia on neonatal brain injury and brain development

2024-8-1

Racial and geographic disparities in neonatal brain care

2024-8-1

TABLE OF CONTENTS

2024-8-1

New treatments: Opportunities and challenges

2024-7-14

Social Determinants of Perinatal Mental Health

2024-7-1

Prenatal depression outcomes in the next generation: a critical review of recent DOHaD studies and recommendations for future research

2024-7-1

A global perspective: Access to mental health care for perinatal populations

2024-7-1

The Importance of Perinatal Non-birthing Parents’ Mental Health and Involvement for Family Health

2024-7-1

Preventive interventions for perinatal mood and anxiety disorders: A review of selected programs

2024-7-1

Models of Care: Opportunities and Challenges

2024-7-1

A systematic review of community-based interventions to address perinatal mental health

2024-7-1

Maternal mental health as a major contributor to maternal mortality

2024-7-1

The parental brain, perinatal mental illness, and treatment: A review of key structural and functional changes

2024-7-1

Reproductive Psychiatry Training: A Critical Component of Access to Perinatal Mental Health Treatment

2024-7-1

Perinatal Mental Health: Research that Moves the Agenda Forward

2024-7-1

The Role of Sleep Protection in Preventing and Treating Postpartum Depression

2024-7-1

Nutrition and the gut-brain axis in neonatal brain injury and development

2024-6-14

How do we reach the goal of personalized medicine for neuroprotection in neonatal hypoxic-ischemic encephalopathy?

2024-6-1

Neonatal-perinatal collaboration during the COVID-19 pandemic

2024-6-1

Introduction

2024-6-1

Neonatal and Infant Infection with SARS-CoV-2

2024-6-1

COVID-19 Therapeutics for the Pregnant Patient

2024-6-1

Protecting and healing the newborn brain through non-pharmacologic and pharmacologic measures

2024-6-1

Disparities in Perinatal COVID-19 Infection and Vaccination

2024-6-1

Standardizing clinician training and patient care in the neonatal neurocritical care: A step-by-step guide

2024-6-1

TABLE OF CONTENTS

2024-6-1

Impact of SARS-CoV-2 infection during pregnancy on the placenta and fetus

2024-6-1

Perinatal COVID-19: Implications for Care of the Newborn

2024-6-1

Using Quality Improvement to Address Social Determinants of Health Needs in Perinatal Care

2024-4-1

A Guide to Critical Appraisal of Quality Improvement Reports

2024-4-1

Building a NICU quality & safety infrastructure

2024-4-1

MASTHEAD

2024-4-1

Improving Parental Mental Health in the Perinatal Period: A Review and Analysis of Quality Improvement Initiatives

2024-4-1

Quality Improvement Efforts Directed at Optimal Umbilical Cord Management in Delivery Room

2024-4-1

Growing Together: Optimization of Care Through Quality Improvement for the Mother/Infant Dyad Affected by Perinatal Opioid Use

2024-4-1

TOPICS

2024-4-1

Quality Improvement and Outcomes for Neonates with Hypoxic-Ischemic Encephalopathy: Obstetrics and Neonatal Perspectives

2024-4-1

The Entwined Circles of Quality Improvement & Advocacy

2024-4-1

Alliance for Innovation on Maternal Health: Evolution of a Program to Address Maternal Morbidity and Mortality

2024-4-1

Perinatal Quality Improvement: Progress, Challenges, and Future Directions

2024-4-1

TABLE OF CONTENTS

2024-4-1

COVER (PMS 486 K)

2024-4-1

MECHANICAL VENTILATION IN SPECIAL POPULATIONS

2024-3-1

Non-invasive versus invasive respiratory support in preterm infants

2024-3-1

Neonatal High Frequency Ventilation: Current Trends and Future Directions

2024-3-1

Volume-Targeted Ventilation

2024-3-1

INTRODUCTION

2024-3-1